Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Retailers Anxiously Await DEA Guidelines On Meth Act, PSE Logbooks

This article was originally published in The Tan Sheet

Executive Summary

Chain drug stores are growing increasingly worried about their ability to implement provisions of the Combat Meth Act before the Sept. 30 deadline as the Drug Enforcement Administration continues to delay issuing its new requirements for sale of pseudoephedrine products, according to NACDS VP-Pharmacy Regulatory Affairs Kevin Nicholson
Advertisement

Related Content

Wyden To Propose Prescription-Only Status For Pseudoephedrine
Wyden To Propose Prescription-Only Status For Pseudoephedrine
Wyden To Propose Prescription-Only Status For Pseudoephedrine
Arkansas e-tracking PSE
Arkansas e-tracking PSE
Arkansas e-tracking PSE
Pseudoephedrine Will Be Behind The Counter Across The Country By October
Pseudoephedrine Will Be Behind The Counter Across The Country By October

Topics

Advertisement
UsernamePublicRestriction

Register

PS099526

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel